1, 5-Disubstituted 1, 2, 3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin K Odlo, J Hentzen, JF dit Chabert, S Ducki, OA Gani, I Sylte, M Skrede, ... Bioorganic & medicinal chemistry 16 (9), 4829-4838, 2008 | 216 | 2008 |
Protein kinase inhibition of clinically important staurosporine analogues OA Gani, RA Engh Natural product reports 27 (4), 489-498, 2010 | 164 | 2010 |
1, 2, 3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents K Odlo, J Fournier-Dit-Chabert, S Ducki, OA Gani, I Sylte, TV Hansen Bioorganic & medicinal chemistry 18 (18), 6874-6885, 2010 | 103 | 2010 |
Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α OA Gani, I Sylte Journal of Molecular Graphics and Modelling 27 (2), 217-224, 2008 | 63 | 2008 |
Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? OA Gani Cardiovascular Diabetology 7, 1-6, 2008 | 61 | 2008 |
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study … NH Birkebaek, C Kamrath, JM Grimsmann, K Aakesson, V Cherubini, ... The Lancet Diabetes & Endocrinology 10 (11), 786-794, 2022 | 45 | 2022 |
Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms L Rødevand, S Bahrami, O Frei, A Lin, O Gani, A Shadrin, OB Smeland, ... Translational Psychiatry 11 (1), 3, 2021 | 40 | 2021 |
Theoretical calculations of the catalytic triad in short-chain alcohol dehydrogenases/reductases OA Gani, OA Adekoya, L Giurato, F Spyrakis, P Cozzini, S Guccione, ... Biophysical Journal 94 (4), 1412-1427, 2008 | 30 | 2008 |
Structural insight into a CE15 esterase from the marine bacterial metagenome C De Santi, OA Gani, R Helland, A Williamson Scientific Reports 7 (1), 17278, 2017 | 24 | 2017 |
Signposts of docking and scoring in drug design OABSM Gani Chemical Biology & Drug Design 70 (4), 360-365, 2007 | 21 | 2007 |
Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches OA Gani, B Thakkar, D Narayanan, KA Alam, P Kyomuhendo, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (10), 1605-1616, 2015 | 18 | 2015 |
Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool E Åberg, B Lund, A Pflug, OA Gani, U Rothweiler, TM de Oliveira, ... Biological chemistry 393 (10), 1121-1129, 2012 | 14 | 2012 |
Evaluating the Predictivity of Virtual Screening for A bl Kinase Inhibitors to Hinder Drug Resistance OA Gani, D Narayanan, RA Engh Chemical Biology & Drug Design 82 (5), 506-519, 2013 | 12 | 2013 |
Ligand‐Induced Stabilization and Activation of Peroxisome Proliferator‐Activated Receptor γ OA Gani, I Sylte Chemical biology & drug design 72 (1), 50-57, 2008 | 12 | 2008 |
A collaborative comparison of international pediatric diabetes registries S Lanzinger, A Zimmermann, AG Ranjan, O Gani, S Pons Perez, ... Pediatric Diabetes 23 (6), 627-640, 2022 | 6 | 2022 |
Phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories revealed by AI-MiXeR AMD Alexey A Shadrin, Oleksandr Frei, Olav B Smeland, Francesco Bettella ... Bioinformatics, 2020 | 5 | 2020 |
Annotation-Informed Causal Mixture Modeling (AI-MiXeR) reveals phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories AA Shadrin, O Frei, OB Smeland, F Bettella, KS O’Connell, O Gani, ... Biorxiv, 772202, 2019 | 4 | 2019 |
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR D Narayanan, OA Gani, FXE Gruber, RA Engh Journal of Cheminformatics 9, 1-19, 2017 | 4 | 2017 |
Årsrapport 2021 T Skrivarhaug, SJ Kummernes, O Gani | 4 | 2013 |
Molecular recognition of long chain fatty acids by peroxisome proliferator-activated receptor α OA Gani, I Sylte Medicinal chemistry research 18, 8-19, 2009 | 3 | 2009 |